12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several healthcare stocks experienced significant movements. Reshape Lifesciences (RSLS) saw a 58.2% increase, while NightHawk Biosciences (NHWK) rose by 12.9%. Minerva Surgical (UTRS) increased by 9.99%, Yield10 Bioscience (YTEN) by 9.5%, Inhibikase Therapeutics (IKT) by 8.33%, and Senti Biosciences (SNTI) by 8.31%. Conversely, LumiraDx (LMDX) fell by 7.7%, Fate Therapeutics (FATE) by 6.67%, Sera Prognostics (SERA) by 5.51%, Gracell Biotechnologies (GRCL) by 5.0%, First Wave BioPharma (FWBI) by 4.84%, and Hepion Pharmaceuticals (HEPA) by 4.82%.
December 12, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inhibikase Therapeutics stock increased by 8.33% to $1.3, with a market cap of $8.0 million.
The 8.33% rise in IKT's stock price may suggest a bullish outlook among investors, potentially leading to further short-term gains.
CONFIDENCE 60
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
NightHawk Biosciences shares increased by 12.9% to $0.35, with a market cap of $9.1 million.
The after-market rise for NHWK suggests that the stock may experience further gains if the positive sentiment carries into the next trading session.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Reshape Lifesciences shares soared 58.2% to $0.4, with a market cap of $5.2 million.
The substantial after-market gain for RSLS indicates strong investor interest which could lead to continued upward movement in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Senti Biosciences stock rose 8.31% to $0.38, with a market value of $16.8 million.
The increase in SNTI's stock price could indicate a positive investor reaction, potentially leading to further short-term appreciation.
CONFIDENCE 55
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Minerva Surgical's stock rose 9.99% to $2.42, with a market cap of $21.4 million.
The near 10% increase in UTRS's stock price suggests potential for continued positive performance in the short term.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Yield10 Bioscience shares went up by 9.5% to $0.22, with outstanding shares valued at $2.6 million.
The 9.5% increase in YTEN's stock price, despite its small market cap, could lead to increased investor interest and a potential short-term uptrend.
CONFIDENCE 65
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Fate Therapeutics shares declined by 6.67% to $2.24, with a market cap of $220.8 million.
The after-market decline for FATE could suggest a bearish trend that may persist in the short term, influenced by investor concerns.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
First Wave BioPharma stock fell 4.84% to $0.29, with a market cap of $3.9 million.
The 4.84% decline in FWBI's stock price suggests a negative investor outlook, which could result in continued downward movement in the short term.
CONFIDENCE 60
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Gracell Biotechnologies shares fell 5.0% to $5.14, with a market value of $493.0 million.
The 5% fall in GRCL's stock price could reflect investor uncertainty or a negative response to market conditions, possibly leading to further declines.
CONFIDENCE 65
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Hepion Pharmaceuticals stock decreased by 4.82% to $3.76, with a market cap of $16.3 million.
The 4.82% drop in HEPA's stock price could be indicative of a bearish sentiment among investors, potentially leading to further short-term declines.
CONFIDENCE 55
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
LumiraDx stock decreased by 7.7% to $0.11, with a market cap of $36.6 million.
The 7.7% decline in LMDX's stock price indicates negative sentiment that could lead to continued downward pressure in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Sera Prognostics shares declined by 5.51% to $4.46, with outstanding shares valued at $139.7 million.
The 5.51% decrease in SERA's stock price may indicate a negative market reaction, potentially leading to further short-term declines.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85